HAL will be down for maintenance from Friday, June 10 at 4pm through Monday, June 13 at 9am. More information
Skip to Main content Skip to Navigation
Journal articles

Use of CDC2 from etoposide-treated cells as substrate to assay CDC25 phosphatase activity

Abstract : Cyclin-dependent kinases (CDKs) regulate the key transition of the cell cycle in all organisms. In response to Etoposide (VP-16) induced DNA damage, cells undergo a G2-phase arrest resulting in the accumulation of inactive CDK1 (CDC2) kinase complexes. Here we report that upon Etoposide treatment CDC2 is phosphorylated on tyrosine 15 and is dephosphorylated and activated in vitro by recombinant CDC25 phosphatase. We also show that inactive CDC2 kinase from Etoposide-treated cells can be used as a substrate in a sensitive two-step assay of CDC25 phosphatase. This assay, which is very simple to set-up, is based on the monitoring of CDC2 kinase activity after CDC25-dependent dephosphorylation. It provides the possibility to use a highly physiological substrate in antimitotic drugs screening.
Document type :
Journal articles
Complete list of metadata

Contributor : Véronique Baldin Connect in order to contact the contributor
Submitted on : Thursday, November 7, 2019 - 12:13:09 PM
Last modification on : Wednesday, October 20, 2021 - 3:44:05 AM


  • HAL Id : hal-02353440, version 1
  • PUBMED : 10368682


C. Cans, V Sert, J de Rycke, Véronique Baldin, B. Ducommun. Use of CDC2 from etoposide-treated cells as substrate to assay CDC25 phosphatase activity. Anticancer Research, International Institute of Anticancer Research, 1999, 19 (2A), pp.1241-4. ⟨hal-02353440⟩



Record views